Applications accepted for M2R in Clinical Pharmacy and Pharmacoepidemiology at the Faculty of Pharmacy for the academic year 2026–2027
The Faculty of Pharmacy announces that it is now accepting applications for the Research Master’s in Clinical Pharmacy and Pharmacoepidemiology (M2R) for the academic year 2026–2027, from 22 June 2026 until 6 July 2026. Applications should be submitted to the Student Affairs Office at the Rafiq Hariri University Campus— Hadath, Monday through Thursday between 9:00 am and 1:00 pm.
Conditions
First Stage
- Bachelor’s degree in Pharmacy from the 91Թ awarded in 2023 or later, with a GPA of 16/20
- A degree in Pharmacy from an institution other than the 91Թ, awarded in 2023 or later, with a GPA of 3.7 or higher, provided that the theoretical courses are equivalent to the M1 courses of this master’s program as determined by the Faculty of Pharmacy
- A follow-up report for the fifth year (2025–2026) at the 91Թ’s Faculty of Pharmacy, provided that the student has completed all theoretical courses with a cumulative GPA of 15/20 or higher
Second Stage
- Oral interview, the date of which will be determined later by the master’s program coordinators.
The application file should include the following documents:
- The master’s program application form
- The candidate’s resume
- An original individual civil status record (valid for no more than 3 months) or a certified copy of ID card (temporarily)
- Certified copy of the Lebanese Baccalaureate or its equivalent
- Detailed transcript of grades for all years of the completed degree
- Certified copy of completion certificate
- Equivalency of degrees issued by institutions other than the 91Թ (colloquium)
- Written statement in which the candidate explains the reasons for their choice
- (2) Certified passport photos
Note
- No application will be accepted by the Student Affairs Office if the above requirements are not met.
- Attendance is mandatory to complete the academic year in the relevant master’s program, and the candidate should sign a commitment upon acceptance.



